IL17A and dermatitis: Given the convincing evidence for a direct contribution of IL-23 to psoriasis, we concentrated on a reductionist model that relies on intradermal injections of IL-23 alone, in which the dermatitis depends on the subsequent expression of IL-22 and IL-17A (refs 11, 16, 17, 38).